← 홈

Antibody

712개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 712개
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Atezolizumab + Trastuzumab + Vinorelbine)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 RECRUITING
AntibodystaleAmgenPhase 2

Bemarituzumab (Bemarituzumab)

Adenocarcinoma · Gastric Cancer

#GastricCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 46.8%임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 2

CRC (Cetuximab, Cetuximab (CRC))

Gastrointestinal Cancer; Digestive System Neoplasms · Incurable Metastatic Colorectal Carcinom

#IncurableMetastaticColorectalCar#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab + Irinotecan (Cetuximab + Irinotecan)

Advanced Colorectal Cancer · FRα

#FR#Antibody#Phase2#항체#면역항체+3
효능 ORR 2.081%임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab + Paclitaxel (Cetuximab + Paclitaxel)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 41.6%임상시험 2상태 DISCONTINUED
AntibodystaleEli LillyPhase 3

Cetuximab, Capecitabine (Cetuximab, Capecitabine)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleRochePhase 3

China-approved Bevacizumab (China-approved Bevacizumab)

Metastatic Colorectal Cancer (CRC) · Advanced Non-squamous Non-small-cell Lun

#AdvancedNon-squamousNon-small-ce#Antibody#Phase3#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleAbbViePhase 1

Cofetuzumab Pelidotin (Cofetuzumab Pelidotin)

Cancer; Non-small Cell Lung Cancer (NSCLC) · Cancer

#Cancer#Antibody#Phase1#항체#면역항체+3
임상시험 2상태 DISCONTINUED
AntibodystaleMacroGenicsPhase 3

Enoblituzumab (Enoblituzumab)

Head and Neck Cancer; Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase3#항체#면역항체+3
효능 ORR 6%임상시험 2상태 DISCONTINUED
AntibodystaleRochePreclinical

atezolizumab (Tecentriq, First line EC/EP+Atezolizumab)

Extensive Stage Small Cell Lung Cancer · Extensive Stage Small Cell Lung Cancer

#ExtensiveStageSmallCellLungCance#Antibody#Preclinical#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleRochePhase 3

HLX87 + Pertuzumab (HLX87 + Pertuzumab)

HER2 + Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 2상태 RECRUITING
AntibodystaleEli Lilly and CompanyPhase 2

cixutumumab (IMC-A12, IMC-A12 (cixutumumab))

Non-Small Cell Lung Cancer · Colon Cancer

#ColonCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 37.9%임상시험 2상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, MK-2206 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleMargaret Gatti-MaysPhase 2

Naxitamab (Naxitamab)

Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleRoswell Park Cancer InstitutePhase 1

Nimotuzumab (Nimotuzumab)

EGFR Gene Mutation; Recurrent Non-Small Cell Lung Carcinoma · Advanced Cancer

#AdvancedCancer#Antibody#Phase1#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleRocheApproved

Oxaliplatin;Capecitabine;Bevacizumab (Oxaliplatin;Capecitabine;Bevacizumab)

Colorectal Cancer; Liver Metastases · Gastric Cancer

#GastricCancer#Antibody#Approved#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleInnoventPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48 combined with Sintilimab and XELOX)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleMerck Sharp & Dohme LLCPhase 2

Robatumumab (Robatumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 DISCONTINUED
AntibodystaleMacroGenicsPhase 3

Tebotelimab (Tebotelimab)

Gastric Cancer; Gastroesophageal Junction Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase3#항체#면역항체+4
효능 ORR 62.5%임상시험 2상태 DISCONTINUED
AntibodystaleBeiGenePhase 2

atezolizumab (Tecentriq, Tislelizumab/Atezolizumab/ Durvalumab/Benmelstobart/Toripalimab/Serplulimab)

Extensive Stage Lung Small Cell Cancer · Extensive Stage Lung Small Cell Cancer

#ExtensiveStageLungSmallCellCance#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 RECRUITING

7 / 36 페이지

← 이전다음 →